Previous Article | Next Article 
Journal of Clinical Microbiology, April 2000, p. 1414-1418, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Quantitation of Human Immunodeficiency Virus Type 1 RNA in Different Biological Compartments
Robin N.
Shepard,1
Jody
Schock,1
Kevin
Robertson,2
Diane C.
Shugars,1,3
John
Dyer,4
Pietro
Vernazza,5
Colin
Hall,2
Myron S.
Cohen,6 and
Susan A.
Fiscus1,*
Department of Microbiology and
Immunology,1 Department of
Neurology,2 Department of Dental
Ecology,3 and Department of
Medicine,6 University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina 27599-7140; St.
Andrews Hospital, Ipswich, Queensland,
Australia4; and Institute for
Clinical Microbiology and Immunology, St. Gallen,
Switzerland5
Received 12 October 1999/Returned for modification 28 December
1999/Accepted 31 January 2000
Little information is available describing viral loads in body
fluids other than blood. In addition, the suitability of commercially available assays for human immunodeficiency virus type 1 (HIV-1) RNA
quantitation has not been evaluated in most nonblood fluids. We
compared Organon Teknika's nucleic acid sequence-based amplification method (NASBA) and Roche's Amplicor HIV-1 Monitor (reverse
transcriptase PCR [RT-PCR]) for quantitating HIV-1 RNA in
cerebrospinal fluid (CSF), saliva, breast milk, seminal plasma, and
cervical-vaginal lavage fluid (CVL). Saliva and breast milk frequently
demonstrated some inhibition in the RT-PCR assay, similar to the
inhibition previously described in seminal plasma. Inhibition of the
RT-PCR assay was not observed with CSF or CVL, nor in any of the NASBA assays. When fluids from HIV-infected individuals were tested by RT-PCR
and NASBA, 73 and 27% of CSF samples and 60 and 40% of breast milk
specimens had detectable RNA, respectively. These differences were not
statistically significant. In cross-sectional studies using RT-PCR to
measure viral RNA in paired blood plasma and CSF samples, 71% of blood
plasma samples and 42% of CSF samples were positive. A similar
analysis using NASBA with paired blood plasma and CVL, saliva, or
seminal plasma samples revealed 91% were blood plasma positive and
55% were CVL positive, 76% were blood plasma positive and 46% were
saliva positive, and 83% were blood plasma positive and 63% were
seminal plasma positive. NASBA worked fairly well to quantitate HIV-1
RNA from all fluids without apparent inhibition. RT-PCR performed well
on CVL and CSF, frequently with greater sensitivity, although its use
in other fluids appears limited due to the presence of inhibitors.
These studies demonstrate that viral loads in nonblood fluids were
generally lower than in blood.
*
Corresponding author. Mailing address: University of
North Carolina at Chapel Hill Department of Microbiology and
Immunology, CB 7140, Chapel Hill, NC 27599-7140. Phone: (919) 966-9872. Fax: (919) 966-9873. E-mail: fiscussa{at}med.unc.edu.
Journal of Clinical Microbiology, April 2000, p. 1414-1418, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
McCormick, A. L., Brown, R. H. Jr, Cudkowicz, M. E., Al-Chalabi, A., Garson, J. A.
(2008). Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology
70: 278-283
[Abstract]
[Full Text]
-
Sherlock, C. H., Lott, P. M., Money, D. M., Merrick, L., Arikan, Y., Remple, V. P., Craib, K., Burdge, D. R.
(2006). Use of Sno Strip Filter-Paper Wicks for Collection of Genital-Tract Samples Allows Reproducible Determination of Human Immunodeficiency Virus Type 1 (HIV-1) RNA Viral Load with a Commercial HIV-1 Viral Load Assay.. J. Clin. Microbiol.
44: 1115-1119
[Abstract]
[Full Text]
-
Wasilk, A., Callahan, J. D., Christopher-Hennings, J., Gay, T. A., Fang, Y., Dammen, M., Reos, M. E., Torremorell, M., Polson, D., Mellencamp, M., Nelson, E., Nelson, W. M.
(2004). Detection of U.S., Lelystad, and European-Like Porcine Reproductive and Respiratory Syndrome Viruses and Relative Quantitation in Boar Semen and Serum Samples by Real-Time PCR. J. Clin. Microbiol.
42: 4453-4461
[Abstract]
[Full Text]
-
Wood, K. L., Chaiyarit, P., Day, R. B., Wang, Y., Schnizlein-Bick, C. T., Gregory, R. L., Twigg, H. L. III
(2003). Measurements of HIV Viral Loads From Different Levels of the Respiratory Tract. Chest
124: 536-542
[Abstract]
[Full Text]
-
Ghosh, M. K., Kuhn, L., West, J., Semrau, K., Decker, D., Thea, D. M., Aldrovandi, G. M.
(2003). Quantitation of Human Immunodeficiency Virus Type 1 in Breast Milk. J. Clin. Microbiol.
41: 2465-2470
[Abstract]
[Full Text]
-
Bourlet, T., Levy, R., Laporte, S., Blachier, S., Bocket, L., Cassuto, G., Chollet, L., Leruez-Ville, M., Maertens, A., Mousnier, F., Pasquier, C., Payan, C., Pellegrin, B., Schvoerer, E., Zavadzki, P., Chouteau, J., Duverlie, G., Izopet, J., Lunel-Fabiani, F., Pawlotsky, J.-M., Profizi, N., Rouzioux, C., Stoll-Keller, F., Thibault, V., Wattre, P., Pozzetto, B.
(2003). Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens. J. Clin. Microbiol.
41: 789-793
[Abstract]
[Full Text]
-
Singer, E. J., Aronow, H. A., Lee, S.-Y., Hinkin, C. H., Lazarus, T.
(2002). Stability of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Determined with the AMPLICOR HIV-1 MONITOR Test, Version 1.5 (Ultrasensitive). J. Clin. Microbiol.
40: 3863-3864
[Abstract]
[Full Text]
-
Bouhlal, H., Chomont, N., Haeffner-Cavaillon, N., Kazatchkine, M. D., Belec, L., Hocini, H.
(2002). Opsonization of HIV-1 by Semen Complement Enhances Infection of Human Epithelial Cells. J. Immunol.
169: 3301-3306
[Abstract]
[Full Text]
-
Si-Mohamed, A., Andreoletti, L., Colombet, I., Carreno, M.-P., Lopez, G., Chatelier, G., Kazatchkine, M. D., Belec, L.
(2001). Quantitation of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Cell-Free Cervicovaginal Secretions: Comparison of Reverse Transcription-PCR Amplification (AMPLICOR HIV-1 MONITOR 1.5) with Enhanced-Sensitivity Branched-DNA Assay (Quantiplex 3.0). J. Clin. Microbiol.
39: 2055-2059
[Abstract]
[Full Text]
-
Hocini, H., Becquart, P., Bouhlal, H., Chomont, N., Ancuta, P., Kazatchkine, M. D., Bélec, L.
(2001). Active and Selective Transcytosis of Cell-Free Human Immunodeficiency Virus through a Tight Polarized Monolayer of Human Endometrial Cells. J. Virol.
75: 5370-5374
[Abstract]
[Full Text]
-
Freel, S. A., Williams, J. M., Nelson, J. A. E., Patton, L. L., Fiscus, S. A., Swanstrom, R., Shugars, D. C.
(2001). Characterization of Human Immunodeficiency Virus Type 1 in Saliva and Blood Plasma by V3-Specific Heteroduplex Tracking Assay and Genotype Analyses. J. Virol.
75: 4936-4940
[Abstract]
[Full Text]
-
Spearman, P., Fiscus, S. A., Smith, R. M., Shepard, R., Johnson, B., Nicotera, J., Harris, V. L., Clough, L. A., McKinsey, J., Haas, D. W.
(2001). Comparison of Roche MONITOR and Organon Teknika NucliSens Assays To Quantify Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid. J. Clin. Microbiol.
39: 1612-1614
[Abstract]
[Full Text]
-
Loeffler, J., Hebart, H., Cox, P., Flues, N., Schumacher, U., Einsele, H.
(2001). Nucleic Acid Sequence-Based Amplification of Aspergillus RNA in Blood Samples. J. Clin. Microbiol.
39: 1626-1629
[Abstract]
[Full Text]
-
Bremer, J., Nowicki, M., Beckner, S., Brambilla, D., Cronin, M., Herman, S., Kovacs, A., Reichelderfer, P.
(2000). Comparison of Two Amplification Technologies for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in the Female Genital Tract. J. Clin. Microbiol.
38: 2665-2669
[Abstract]
[Full Text]